A carregar...
Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes: A 24-week, randomized, double-blind, placebo-controlled trial
OBJECTIVE: To investigate the efficacy and tolerability of empagliflozin as add-on to metformin and sulfonylurea in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: Patients inadequately controlled on metformin and sulfonylurea (HbA(1c) ≥7 to ≤10%) were randomized and treated with once-da...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Diabetes Association
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3816918/ https://ncbi.nlm.nih.gov/pubmed/23963895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-2673 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|